Literature DB >> 16955230

A locus for familial skewed X chromosome inactivation maps to chromosome Xq25 in a family with a female manifesting Lowe syndrome.

Milena Cau1, Maria Addis1, Rita Congiu1, Cristiana Meloni1, Antonio Cao2, Simona Santaniello1, Mario Loi3, Francesco Emma4, Orsetta Zuffardi5,6, Roberto Ciccone5, Gabriella Sole2, Maria Antonietta Melis7.   

Abstract

In mammals, X-linked gene products can be dosage compensated between males and females by inactivation of one of the two X chromosomes in the developing female embryos. X inactivation choice is usually random in embryo mammals, but several mechanisms can influence the choice determining skewed X inactivation. As a consequence, females heterozygous for X-linked recessive disease can manifest the full phenotype. Herein, we report a family with extremely skewed X inactivation that produced the full phenotype of Lowe syndrome, a recessive X-linked disease, in a female. The X chromosome inactivation studies detected an extremely skewed inactivation pattern with a ratio of 100:0 in the propositus as well as in five out of seven unaffected female relatives in four generations. The OCRL1 "de novo" mutation resides in the active paternally inherited X chromosome. X chromosome haplotype analysis suggests the presence of a locus for the familial skewed X inactivation in chromosome Xq25 most likely controlling X chromosome choice in X inactivation or cell proliferation. The description of this case adds Lowe syndrome to the list of X-linked disorders which may manifest the full phenotype in females because of the skewed X inactivation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16955230     DOI: 10.1007/s10038-006-0049-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  20 in total

1.  [A girl with Lowe's syndrome].

Authors:  H G SCHOLTEN
Journal:  Maandschr Kindergeneeskd       Date:  1960-07

2.  Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity.

Authors:  C U LOWE; M TERREY; E A MacLACHLAN
Journal:  AMA Am J Dis Child       Date:  1952-02

3.  Physical mapping and genomic structure of the Lowe syndrome gene OCRL1.

Authors:  R L Nussbaum; B M Orrison; P A Jänne; L Charnas; A C Chinault
Journal:  Hum Genet       Date:  1997-02       Impact factor: 4.132

4.  Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human.

Authors:  A K Naumova; L Olien; L M Bird; M Smith; A E Verner; M Leppert; K Morgan; C Sapienza
Journal:  Eur J Hum Genet       Date:  1998 Nov-Dec       Impact factor: 4.246

5.  A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation.

Authors:  R M Plenge; B D Hendrich; C Schwartz; J F Arena; A Naumova; C Sapienza; R M Winter; H F Willard
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

Review 6.  Random X-chromosome inactivation: skewing lessons for mice and men.

Authors:  Philippe Clerc; Philip Avner
Journal:  Curr Opin Genet Dev       Date:  2006-05-02       Impact factor: 5.578

7.  Oculo-cerebro-renal syndrome. Report of a case in a baby girl.

Authors:  L S Harris; K A Gitter; M A Galin; G P Plechaty
Journal:  Br J Ophthalmol       Date:  1970-04       Impact factor: 4.638

8.  Glycosaminoglycan synthesis by cultured skin fibroblasts from a patient with Lowe's syndrome.

Authors:  S Fukui; H Yoshida; T Tanaka; T Sakano; T Usui; I Yamashina
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

9.  Lowe oculocerebrorenal syndrome in a female with a balanced X;20 translocation: mapping of the X chromosome breakpoint.

Authors:  O T Mueller; J K Hartsfield; L A Gallardo; Y P Essig; K L Miller; P R Papenhausen; T A Tedesco
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

10.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

Authors:  R C Allen; H Y Zoghbi; A B Moseley; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

View more
  9 in total

1.  Human X-chromosome inactivation pattern distributions fit a model of genetically influenced choice better than models of completely random choice.

Authors:  Nisa K E Renault; Sonja M Pritchett; Robin E Howell; Wenda L Greer; Carmen Sapienza; Karen Helene Ørstavik; David C Hamilton
Journal:  Eur J Hum Genet       Date:  2013-05-08       Impact factor: 4.246

2.  Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.

Authors:  Katsusuke Yamamoto; Yasuhiro Hasegawa; Yasuhisa Ohata; Kenichi Satomura; Yoshimi Mizoguchi; Tsunesuke Shimotsuji; Takehisa Yamamoto
Journal:  CEN Case Rep       Date:  2019-11-09

Review 3.  The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

Authors:  Maria Antonietta De Matteis; Leopoldo Staiano; Francesco Emma; Olivier Devuyst
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

Review 4.  Phosphoinositides in the kidney.

Authors:  Leopoldo Staiano; Maria Antonietta De Matteis
Journal:  J Lipid Res       Date:  2018-10-12       Impact factor: 5.922

5.  Identification and functional characterization of a hemizygous novel intronic variant in OCRL gene causes Lowe syndrome.

Authors:  Junhui Sun; Zhongwei Zhou; Chen Weng; Chaojun Wang; Jiao Chen; Xue Feng; Ping Yu; Ming Qi
Journal:  Clin Exp Nephrol       Date:  2020-05-11       Impact factor: 2.801

6.  Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism.

Authors:  Maria H Chahrour; Timothy W Yu; Elaine T Lim; Bulent Ataman; Michael E Coulter; R Sean Hill; Christine R Stevens; Christian R Schubert; Michael E Greenberg; Stacey B Gabriel; Christopher A Walsh
Journal:  PLoS Genet       Date:  2012-04-12       Impact factor: 5.917

7.  Demonstration of a novel Xp22.2 microdeletion as the cause of familial extreme skewing of X-inactivation utilizing case-parent trio SNP microarray analysis.

Authors:  Jane A Mason; Hnin T Aung; Adayapalam Nandini; Rickie G Woods; David J Fairbairn; John A Rowell; David Young; Rachel D Susman; Simon A Brown; Valentine J Hyland; Jeremy D Robertson
Journal:  Mol Genet Genomic Med       Date:  2018-02-28       Impact factor: 2.183

8.  Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy.

Authors:  Jonàs Juan-Mateu; Maria José Rodríguez; Andrés Nascimento; Cecilia Jiménez-Mallebrera; Lidia González-Quereda; Eloy Rivas; Carmen Paradas; Marcos Madruga; Pedro Sánchez-Ayaso; Cristina Jou; Laura González-Mera; Francina Munell; Manuel Roig-Quilis; Maria Rabasa; Aurelio Hernández-Lain; Jorge Díaz-Manera; Eduard Gallardo; Jordi Pascual; Edgard Verdura; Jaume Colomer; Montserrat Baiget; Montse Olivé; Pia Gallano
Journal:  Orphanet J Rare Dis       Date:  2012-10-23       Impact factor: 4.123

9.  Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita.

Authors:  M G Shaikh; L Boyes; H Kingston; R Collins; G T N Besley; B Padmakumar; O Ismayl; I Hughes; C M Hall; C Hellerud; J C Achermann; P E Clayton
Journal:  J Med Genet       Date:  2008-09       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.